An exploratory study of SHR6390 in the treatment of CDK4 amplified malignant melanoma of head and neck mucosa after standard treatment failure
Latest Information Update: 04 Dec 2020
Price :
$35 *
At a glance
- Drugs Dalpiciclib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 04 Dec 2020 New trial record